Skip to main content

Table 4 Number of patients with active extra-MSK manifestations and the number of decision-making

From: Extra-musculoskeletal manifestations driving the therapeutic decision-making in patients with Spondyloarthritis: a 12-month follow-up prospective cohort study

EmM

Baseline

3 months

6 months

12 months

p

Active rAAU, n (%)

48 (100%)

11 (22.9%)

10 (20.8%)

7 (14.6%)

 < 0.001

DECISION-MAKING*, N (%)

48 (100%)

10 (91%)

9 (90%)

7 (100%)

 < 0.001

ACTIVE PS, N (%)

78 (100%)

55 (70.5%)

45 (57.7%)

40 (51.3%)

 < 0.001

DECISION-MAKING*, N (%)

78 (100%)

30 (54.5%)

26 (57.8%)

14 (35%)

 < 0.0001

ACTIVE IBD, N (%)

14 (93.3%)

8 (53.3%)

4 (26.7%)

4 (26.7%)

 < 0.001

  1. EMM: extramusculoskeletal manifestation; rAAU: recurrent acute anterior uveitis; Ps: psoriasis; EAM
  2. *Regarding the number of patients that still had an active EAM
Back to article page

Advances in Rheumatology

ISSN: 2523-3106